reported in this journal a study, using the mixed cell agglutination technique, of bladder tumour cells. His results showed a rough correlation between the strength of agglutination and the degree of malignancy as judged histologically, and he found a general pattern of weaker agglutination associated with greater malignancy. This was not constant, however, since one well differentiated tumour was totally unagglutinable, while two anaplastic pleomorphic growths gave normal, strong agglutination. The present study, suggested by Kay's work, reports the findings, using mixed cell agglutination, on thirty-two malignant tumours of the human stomach and large bowel.
malignant tumours of the human stomach and large bowel.
METHODS
Specimens of gastric and colonic carcinomata were obtained from the operating theatre within fifteen minutes of resection. The viscus was opened, mucus and faeces gently washed away with tap water and the lesion examined. Two samples of tissue were then taken in each case. A small piece of the surface of the growth was removed with a sharp knife, and a piece of unaffected mucosa from an adjacent part of the organ was also taken. Both specimens were stored separately at -20°C. in 20 per cent glycerol in saline. The organ was then placed in formol saline for routine histological study. As soon as convenient, but usually within a few days, a mucosal cell suspension of both malignant and normal tissue was made, using a solution of oxidised ascorbic acid (Cowan, 1962) . The suspensions were stored, like the tissues, in 20 per cent glycerol in saline at -200 C. A scraping of buccal cells from each patient was obtained in the post-operative period; these cells were stored in suspension in the same manner as the gastrointestinal cells and mixed cell agglutination performed on them served as a control of technique. Finally, a specimen of saliva, and often gastric juice in addition, was secured from each patient and the secretor status determined by the method of antibody-inhibition (Race and Sanger, 1958) .
Mixed cell agglutination was performed after the manner described by Coombs, Bedford and Rouillard (1956) The results are represented in Table I .
DISCUSSION
It is possible that the weaker agglutination in colonic specimens was due to bacterial contamination of the tissue cells, in spite of the bacteriocidal action of the oxidized ascorbic acid solution used to disperse the cells and in spite of the comparative expediency with which tissue was obtained once it had been removed from the patient. Broberger and Perlman (1959) were very conscious of this effect of bacterical contamination, and in obtaining specimens of human colon for the preparation of antigen, selected colons of newborn infants who had died soon after birth and before they had been fed. On the other hand, this poor agglutination may well reflect diminished antigen content of the cells. Hartmann (1941) found that the blood group antigen content of the gastrointestinal tract epithelium diminished gradually from the stomach towards the rectum both in secretors and non-secretors, and in two specimens of colon resected for carcinoma from group A patients of undetermined secretor status, Glynn and Holborow (1959) were able to obtain only traces of staining in the mucosa. Moreover, Szulman (Weiler, 1956; Nairn et al., 1960) In the present study, stronger agglutination than normal was shown in four of thirty-two tumours, a finding which represents an apparent antigen gain in these cases. The greater degree of agglutination was not due to the tumours being mucus-secreting and therefore containing excessive blood-group substance; only one of the four tumours on serial sectioning was mucus-secreting in type, and one of the tumours showing weaker agglutination than normal presented a similar histological picture. Both Weiler (1959) and Green (1959) in their studies of antigen loss in carcinogenesis felt that there might, on occasions, be some antigen gain by tumour cells, but they concluded that such gains were not organ specific. Again, Nairn, Richmond and Fothergill (1960) , using the fluorescent antibody technique to stain normal and malignant cells with non-immune rabbit globulin, reported that in some carcinomata (although never in the colon), brighter staining was obtained with tumour tissue. On the more relevant plane of blood group antigens, Zacho (1932) was able to demonstrate MN antigens in malignant tumours, but never in benign.
Of the four instances in the present work where stronger agglutination occurred with tumour tissue (No. C4, C9, C20, C22), all were tumours of the colon and three of the four were from group B patients, indeed the only group B colonic tissues examined. Springer et al. (1956) have demonstrated in E. coli 086 a polysaccharide having powerful group B activity, and it is possible that malignant cells are able to take up from the bowel bacterial exotoxins containing such antigen to a greater degree than normal cells. The taking up of such toxins has been put forward as an explanation of the occasional acquisition of group B antigen by red cells (Stratton and Renton, 1959) , although later work demonstrating the presence of A antigen as well as B in this strain of E. colti (Gonano, Modiano and Andreis, 1961; Pettenkofer, Maassen and Bickerich, 1960) poses a further complication. It is of interest, however, that in four communications reporting the acquisition of blood group B antigen by red cells (Cameron et al., 1959; Giles et al., 1959; Marsh, Jenkins and Walther, 1959; Stratton and Renton, 1959) , a total of twelve patients are described of whom eight had carcinoma of the colon or rectum.
It might be supposed that even if a malignant cell has lost its own intrinsic antigen, it might, in secretors, adsorb antigen from the lumen of the gut, although this consideration might not operate so forcibly in the colon where the antigen level of the bowel contents is not so great (Witebsky and Neter, 1935) . If malignant cells do, in fact, lose intrinsic antigen, then this point could explain why this is often not apparent, but if, in secretors, one still discovers loss of antigen, then the finding is the more significant. Kay (1957) , in assessing his results, draws attention to features of the malignant cell such as decreased adherence, irregularity of the surface and increased negative charge which could militate against strong mixed cell agglutination, and he feels that the results should perhaps be interpreted in the light of these factors rather than postulating a graded loss of blood group antigen. Such considerations cannot be applied, however, to those instances in the present study of increased agglutination on tumour cells, and the final impression is that while physical alteration of the surface of the malignant cell may well complicate the issue, malignant change in gastointestinal cells can often be attended by some alteration of the blood group antigen content. SUMMARY Thirty-two malignant tumours of the human gastrointestinal tract have been examined for blood group antigen by mixed cell agglutination and the results compared with adjacent normal tissue. The buccal cells of the patients have also been examined by mixed cell agglutination and the secretor status of the individuals determined.
In sixteen of the tumours examined, agglutination was not as strong as in the normal tissue and in four tumours the degree of agglutination was greater than normal.
This work was part of a project the results of which were submitted as a thesis for the degree of M.D. of the University of Liverpool. I am deeply grateful to Dr. R. R. A. Coombs for much help and at whose suggestion the work was done. Mr. W. T. A. Donohoe of the Department of Medicine, University of Liverpool, was responsible for the skilful serological testing of the specimens of saliva and gastric juice.
